Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

by Falcone Alfredo, Salvatore Lisa, Cremolini Chiara, Carlini Paolo, Milella Michele, Cuppone Federica, Vaccaro Vanja, Bria Emilio, Loupakis Fotios, Muti Paola, Sperduti Isabella, Giannarelli Diana, Cognetti Francesco
Published 2010-05-01

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in sit...

by Scartozzi Mario, Bearzi Italo, Mandolesi Alessandra, Pierantoni Chiara, Loupakis Fotios, Zaniboni Alberto, Negri Francesca, Quadri Antonello, Zorzi Fausto, Galizia Eva, Berardi Rossana, Biscotti Tommasina, Labianca Roberto, Masi Gianluca, Falcone Alfredo, Cascinu Stefano
Published 2009-08-01

Retrospective exploratory analysis of <it>VEGF </it>polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

by Manzoni Mariangela, Ricci Vincenzo, Bencardino Katia, Santini Daniele, Vincenzi Bruno, Canestrari Emanuele, Galluccio Nadia, Catalano Vincenzo, Frumento Paolo, Schirripa Marta, Masi Gianluca, Cremolini Chiara, Ruzzo Annamaria, Salvatore Lisa, Loupakis Fotios, Danova Marco, Tonini Giuseppe, Magnani Mauro, Falcone Alfredo, Graziano Francesco
Published 2011-06-01